Novartis faces questions over tumours reported after Zolgensma treatment
Novartis faces questions over tumours reported after Zolgensma treatment
The report was published on 06 de novembro de 2026 às 13:40 by FirstWord PHARMA and is part of the World news coverage.
What other outlets are saying
- BioSpace: Novartis confirms 9 reported cases of tumors in patients treated with Zolgensma
- Endpoints News: Seven new tumor cases reported among patients on Novartis’ Zolgensma gene therapy
- BioSpace: Novartis confirms 9 reported cases of tumors in patients treated with Zolgensma
- apotheke adhoc: Zolgensma: Novartis bestätigt Tumorfälle
- Börse Online: Novartis meldet Tumorfälle bei Kindern nach Zolgensma-Behandlung
Quick answers
Who reported this story?
It was first reported by FirstWord PHARMA on 06 de novembro de 2026 às 13:40.
What is the category?
It is filed under World news on Rio Warzone News.
